MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Do environmental factors influence the age at onset of Parkinson’s disease in LRRK2 G2019S carriers?

S. Elincx-Benizri, L. Greenbaum, G. Yahalom, T. Tsafnat, S. Israeli-Korn, O.S. Cohen, H. Strauss, S. May, R. Djaldetti, N. Warman Alaluf, S. Hassin-Baer (Ramat Gan, Israel)

Meeting: 2016 International Congress

Abstract Number: 657

Keywords: Environmental toxins

Session Information

Date: Tuesday, June 21, 2016

Session Title: Parkinson's disease: Genetics

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To evaluate the influence of environmental factors on the age at onset of Parkinson’s disease in LRRK2 G2019S carriers.

Background: Environmental and lifestyle factors contribute to the risk for sporadic Parkinson’s disease (PD), and may also modify age at onset (AAO). PD that is associated with the Gly2019Ser (G2019S) mutation of the LRRK2 gene, a common mutation in the Ashkenazi Jewish (AJ) population, represents a homogeneous subgroup that may serve a good platform to assess the contribution of environmental factors to age at onset (AAO) of PD. Based on previous epidemiological studies, we hypothesized that mutation carriers exposed to certain known PD risk factors will have earlier AAO compared to those that were not exposed, while opposite direction may be found for PD protective factors.

Methods: PD patients carrying the LRRK2 G2019S mutation were matched (1:1 ratio, regarding gender and year of birth) to PD patients who were negative for this mutation, and all completed an interviewer-administered lifestyle and environmental exposure questionnaire, addressing smoking habits, coffee, tea and alcohol consumption, history of head trauma (with or without loss of consciousness) and rural residence during lifetime.

Results: The sample included 84 Israeli AJ LRRK2 PD patients positive for the G2019S mutation (females: 48.8%; AAO: 58.8 ± 8.8 years) and 84 matched AJ PD controls (AAO: 60.6 ± 6.4 years). Controlling for gender and year of birth, we did not find any interaction between mutation carrier status and environmental exposures with AAO. Lack of effect was also observed when analysis was performed separately for LRRK2-positive and negative patients.

Conclusions: While LRRK2-associated PD renders unique opportunity to assess interaction between genetic and environmental factors, in this exploratory study, we did not find an effect of any of the environmental factors examined on AAO among PD patients, neither LRRK2 mutation carriers nor controls. This may be explained by the small sample size.

At the Israeli Neurological Association Congress; December 15-16, 2015.

To cite this abstract in AMA style:

S. Elincx-Benizri, L. Greenbaum, G. Yahalom, T. Tsafnat, S. Israeli-Korn, O.S. Cohen, H. Strauss, S. May, R. Djaldetti, N. Warman Alaluf, S. Hassin-Baer. Do environmental factors influence the age at onset of Parkinson’s disease in LRRK2 G2019S carriers? [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/do-environmental-factors-influence-the-age-at-onset-of-parkinsons-disease-in-lrrk2-g2019s-carriers/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/do-environmental-factors-influence-the-age-at-onset-of-parkinsons-disease-in-lrrk2-g2019s-carriers/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley